首页 > 最新文献

Arquivos de Gastroenterologia最新文献

英文 中文
PEDIATRIC CHOLELITHIASIS AND FACTORS ASSOCIATED WITH CHOLECYSTECTOMY.
Q2 Medicine Pub Date : 2025-02-17 eCollection Date: 2025-01-01 DOI: 10.1590/S0004-2803.24612024-048
Karyne Sumico de Lima Uyeno Jordão, Matheus Guedes da Silva, Gabriel Hessel, Roberto Massao Yamada, Joaquim Murray Bustorff-Silva, Maria Ângela Bellomo-Brandão

Background: Cholelithiasis, characterized by hardened deposits in the gallbladder, presents symptoms such as abdominal pain, jaundice, nausea, and potential complications like cholecystitis and choledocholithiasis. Despite increasing diagnoses, literature on pediatric cholelithiasis is limited, with undefined protocols.

Objective: This study aims to evaluate the clinical, laboratory characteristics, and outcomes of pediatric cholelithiasis cases, identifying factors associated with cholecystectomy.

Methods: A retrospective case series study was conducted on patients treated at a tertiary service, diagnosed with cholelithiasis via ultrasound from 2007 to 2021. Clinical profiles, comorbidities, examinations, procedures, and patient evolution were assessed. Patients were categorized into two groups: Group NC (no cholecystectomy) and Group C (cholecystectomy).

Results: Thirty-five patients were included, with 51% females and 60% having comorbidities with abdominal pain was the predominant symptom. Thirty-three patients were managed outpatient while two patients continued follow-up at another facility. Twelve opted for expectant management (Group NC), while 21 underwent cholecystectomy (Group C). Elective laparoscopic cholecystectomy was performed in Group C, with a median age of 11 years and 3 months. Group C showed a higher frequency of abdominal pain compared to Group NC, and this difference was significant (P=0.04). No differences were observed in gender, comorbidities, jaundice, fever, laboratory findings, symptom duration, follow-up time, or age at diagnosis. The median follow-up duration in Group NC was 1 year and 7 months.

Conclusion: Abdominal pain was the predominant symptom in patients undergoing cholecystectomy, while comorbidities and laboratory abnormalities showed no significant associations. Although surgical intervention is typically recommended, expectant management proved viable in select cases without ensuing complications during the evaluation period.

{"title":"PEDIATRIC CHOLELITHIASIS AND FACTORS ASSOCIATED WITH CHOLECYSTECTOMY.","authors":"Karyne Sumico de Lima Uyeno Jordão, Matheus Guedes da Silva, Gabriel Hessel, Roberto Massao Yamada, Joaquim Murray Bustorff-Silva, Maria Ângela Bellomo-Brandão","doi":"10.1590/S0004-2803.24612024-048","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-048","url":null,"abstract":"<p><strong>Background: </strong>Cholelithiasis, characterized by hardened deposits in the gallbladder, presents symptoms such as abdominal pain, jaundice, nausea, and potential complications like cholecystitis and choledocholithiasis. Despite increasing diagnoses, literature on pediatric cholelithiasis is limited, with undefined protocols.</p><p><strong>Objective: </strong>This study aims to evaluate the clinical, laboratory characteristics, and outcomes of pediatric cholelithiasis cases, identifying factors associated with cholecystectomy.</p><p><strong>Methods: </strong>A retrospective case series study was conducted on patients treated at a tertiary service, diagnosed with cholelithiasis via ultrasound from 2007 to 2021. Clinical profiles, comorbidities, examinations, procedures, and patient evolution were assessed. Patients were categorized into two groups: Group NC (no cholecystectomy) and Group C (cholecystectomy).</p><p><strong>Results: </strong>Thirty-five patients were included, with 51% females and 60% having comorbidities with abdominal pain was the predominant symptom. Thirty-three patients were managed outpatient while two patients continued follow-up at another facility. Twelve opted for expectant management (Group NC), while 21 underwent cholecystectomy (Group C). Elective laparoscopic cholecystectomy was performed in Group C, with a median age of 11 years and 3 months. Group C showed a higher frequency of abdominal pain compared to Group NC, and this difference was significant (P=0.04). No differences were observed in gender, comorbidities, jaundice, fever, laboratory findings, symptom duration, follow-up time, or age at diagnosis. The median follow-up duration in Group NC was 1 year and 7 months.</p><p><strong>Conclusion: </strong>Abdominal pain was the predominant symptom in patients undergoing cholecystectomy, while comorbidities and laboratory abnormalities showed no significant associations. Although surgical intervention is typically recommended, expectant management proved viable in select cases without ensuing complications during the evaluation period.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"62 ","pages":"e24048"},"PeriodicalIF":0.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.
Q2 Medicine Pub Date : 2025-02-17 eCollection Date: 2025-01-01 DOI: 10.1590/S0004-2803.24612024-107
Bruno César da Silva, Gabriela Piovezani Ramos, Luisa Leite Barros, Ana Flávia Passos Ramos, Gerson Domingues, Décio Chinzon, Maria do Carmo Friche Passos

Background: Small intestinal bacterial overgrowth (SIBO) is a condition characterized by an abnormal increase in bacterial population in the small intestine, leading to symptoms such as bloating, abdominal pain, distension, diarrhea, and eventually malabsorption. The diagnosis and management of SIBO remain challenging due to overlapping symptoms with other gastrointestinal disorders such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and coeliac disease.

Objective: This article aims to review current evidence on the diagnosis and treatment of SIBO, with a focus on strategies suitable for the Brazilian healthcare system.

Methods: A comprehensive literature review was performed, focusing on clinical guidelines, randomized controlled trials, and cohort studies concerning SIBO. Diagnostic methods, including breath tests and direct aspiration techniques, were critically analyzed. Treatment approaches, including antibiotics, dietary modifications, and probiotics, were reviewed. The recommendations were formulated based on a panel of gastroenterologists, members of the Brazilian Federation of Gastroenterology (FBG), with approval from the majority of the members.

Results: Breath tests using glucose and lactulose remain the most commonly used non-invasive diagnostic tools, though they are subject to limitations such as false positives and false negatives. Treatment with rifaximin is effective in most cases of SIBO, while systemic antibiotics like metronidazole and ciprofloxacin are alternatives. Probiotics and dietary interventions, particularly low FODMAP diets, can complement antibiotic therapy. Long-term follow-up is essential due to the recurrence rate, which is common in SIBO patients.

Conclusion: Standardizing SIBO diagnosis and treatment in Brazil is essential to reduce diagnostic delays and optimize care, especially given the disparities and heterogeneity in clinical practice across the country. This article provides evidence-based recommendations to guide clinical practice. Further research is needed to refine diagnostic methods, explore novel treatment strategies, and better understand the specific characteristics of the Brazilian population.

{"title":"DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.","authors":"Bruno César da Silva, Gabriela Piovezani Ramos, Luisa Leite Barros, Ana Flávia Passos Ramos, Gerson Domingues, Décio Chinzon, Maria do Carmo Friche Passos","doi":"10.1590/S0004-2803.24612024-107","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-107","url":null,"abstract":"<p><strong>Background: </strong>Small intestinal bacterial overgrowth (SIBO) is a condition characterized by an abnormal increase in bacterial population in the small intestine, leading to symptoms such as bloating, abdominal pain, distension, diarrhea, and eventually malabsorption. The diagnosis and management of SIBO remain challenging due to overlapping symptoms with other gastrointestinal disorders such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and coeliac disease.</p><p><strong>Objective: </strong>This article aims to review current evidence on the diagnosis and treatment of SIBO, with a focus on strategies suitable for the Brazilian healthcare system.</p><p><strong>Methods: </strong>A comprehensive literature review was performed, focusing on clinical guidelines, randomized controlled trials, and cohort studies concerning SIBO. Diagnostic methods, including breath tests and direct aspiration techniques, were critically analyzed. Treatment approaches, including antibiotics, dietary modifications, and probiotics, were reviewed. The recommendations were formulated based on a panel of gastroenterologists, members of the Brazilian Federation of Gastroenterology (FBG), with approval from the majority of the members.</p><p><strong>Results: </strong>Breath tests using glucose and lactulose remain the most commonly used non-invasive diagnostic tools, though they are subject to limitations such as false positives and false negatives. Treatment with rifaximin is effective in most cases of SIBO, while systemic antibiotics like metronidazole and ciprofloxacin are alternatives. Probiotics and dietary interventions, particularly low FODMAP diets, can complement antibiotic therapy. Long-term follow-up is essential due to the recurrence rate, which is common in SIBO patients.</p><p><strong>Conclusion: </strong>Standardizing SIBO diagnosis and treatment in Brazil is essential to reduce diagnostic delays and optimize care, especially given the disparities and heterogeneity in clinical practice across the country. This article provides evidence-based recommendations to guide clinical practice. Further research is needed to refine diagnostic methods, explore novel treatment strategies, and better understand the specific characteristics of the Brazilian population.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"62 ","pages":"e24107"},"PeriodicalIF":0.0,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COLLABORATIVE NETWORKS IN GASTROENTEROLOGY RESEARCH: A CO-AUTHORSHIP NETWORK ANALYSIS (2000-2023). 胃肠病学研究中的合作网络:合作作者网络分析(2000-2023)。
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-083
Naruaki Ogasawara

Background: This study aims to analyze the co-authorship network in Gastroenterology research, focusing on publications from 2000 to 2023, to understand the collaborative relationships among researchers and identify key contributors in the field.

Methods: Using data from the Web of Science (WoS), I examined 18,855 Gastroenterology-related articles published between 2000 and 2023. The analysis was conducted using Python within the PyCharm environment. I assessed the network at both macro and micro levels. Macro-level indicators included network density, clustering coefficient, components, and average path length. Micro-level indicators included degree centrality, closeness centrality, and betweenness centrality, which helped identify influential researchers and research groups.

Results: The analysis revealed an evolution from a fragmented and sparsely connected network in the early 2000s to a more interconnected structure in recent years. Despite the overall increase in network density and clustering, full integration was not achieved, with many researchers remaining in isolated clusters. Key researchers such as Gasbarrini G., Vandenplas Y., and Hassan C. were identified as central figures within the network, playing crucial roles in fostering collaboration.

Conclusion: The study highlights the ongoing development of collaborative networks in Gastroenterology research, identifying influential researchers and groups that drive advancements in the field. The findings provide valuable insights for enhancing future research collaborations, particularly in areas where Japan excels, such as endoscopic technology.

背景:本研究旨在分析胃肠病学研究的合著者网络,重点分析2000年至2023年发表的论文,了解研究人员之间的合作关系,并确定该领域的关键贡献者。方法:使用来自Web of Science (WoS)的数据,我检查了2000年至2023年间发表的18855篇胃肠病学相关文章。分析是在PyCharm环境中使用Python进行的。我从宏观和微观两个层面对网络进行了评估。宏观指标包括网络密度、聚类系数、成分、平均路径长度等。微观层面的指标包括度中心性、接近中心性和中间中心性,这些指标有助于确定有影响力的研究人员和研究小组。结果:分析表明,从21世纪初的碎片化和稀疏连接的网络到近年来更加相互关联的结构的演变。尽管网络密度和聚类总体上有所增加,但没有实现完全的整合,许多研究人员仍然处于孤立的集群中。Gasbarrini G.、Vandenplas Y.和Hassan C.等关键研究人员被认为是网络中的核心人物,在促进合作方面发挥着关键作用。结论:该研究突出了胃肠病学研究中协作网络的持续发展,确定了推动该领域进步的有影响力的研究人员和团体。这些发现为加强未来的研究合作提供了有价值的见解,特别是在日本擅长的领域,如内窥镜技术。
{"title":"COLLABORATIVE NETWORKS IN GASTROENTEROLOGY RESEARCH: A CO-AUTHORSHIP NETWORK ANALYSIS (2000-2023).","authors":"Naruaki Ogasawara","doi":"10.1590/S0004-2803.24612024-083","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-083","url":null,"abstract":"<p><strong>Background: </strong>This study aims to analyze the co-authorship network in Gastroenterology research, focusing on publications from 2000 to 2023, to understand the collaborative relationships among researchers and identify key contributors in the field.</p><p><strong>Methods: </strong>Using data from the Web of Science (WoS), I examined 18,855 Gastroenterology-related articles published between 2000 and 2023. The analysis was conducted using Python within the PyCharm environment. I assessed the network at both macro and micro levels. Macro-level indicators included network density, clustering coefficient, components, and average path length. Micro-level indicators included degree centrality, closeness centrality, and betweenness centrality, which helped identify influential researchers and research groups.</p><p><strong>Results: </strong>The analysis revealed an evolution from a fragmented and sparsely connected network in the early 2000s to a more interconnected structure in recent years. Despite the overall increase in network density and clustering, full integration was not achieved, with many researchers remaining in isolated clusters. Key researchers such as Gasbarrini G., Vandenplas Y., and Hassan C. were identified as central figures within the network, playing crucial roles in fostering collaboration.</p><p><strong>Conclusion: </strong>The study highlights the ongoing development of collaborative networks in Gastroenterology research, identifying influential researchers and groups that drive advancements in the field. The findings provide valuable insights for enhancing future research collaborations, particularly in areas where Japan excels, such as endoscopic technology.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24083"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UTILITY OF ENDOSCOPIC NARROW-BAND IMAGING FOR IDENTIFYING H. PYLORI-ASSOCIATED GASTRITIS IN CHILDREN. 内镜窄带成像在鉴别儿童幽门螺杆菌相关胃炎中的应用。
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-067
Pooja Semwal, Rishi Bolia, Nowneet Kumar Bhat, Itish Patnaik, Prashant Durgapal, Rahul Sharma

Background: Conventional white light endoscopic (WLE) findings of H. pylori-associated gastritis are often non-specific and may not correlate with histology. Narrow band imaging (NBI), an optical digital technique employed for the visualization of vessels and patterns of gastric mucosa may improve identification. We evaluated the role of NBI in detecting H. pylori-associated gastritis and classifying its severity.

Methods: Institution-based prospective observational study conducted between May 2021-October 2022. Children presenting with chronic abdominal pain (>1-month duration) were evaluated. Eligible children underwent gastroscopy with NBI and gastric biopsies for rapid urease test and histopathology. NBI gastroscopic findings were classified into five grades as per the classification by Alboudy et al. The association of NBI grade with the presence and severity of H. pylori gastritis on histopathology was analysed.

Results: Ninety children (mean age 12.65±3.91 years), 52 (57.7%) males with median duration of symptoms of 4.5 (3-12) months underwent gastroscopy. H. pylori was detected on histopathology in 29 (32%) patients. NBI findings suggested a mucosal abnormality in 27/29 (93.1%) children with H. pylori on histopathology. H. pylori positive gastritis was significantly more common among those with higher (≥3) NBI grades as compared to those with lower NBI grades (61% vs10%, P<0.001). No significant association was found between NBI grade and the severity of H. pylori gastritis (P=0.75). NBI exhibited better sensitivity (0.82) compared to WLE (0.55) in identifying H. pylori-associated gastritis. On receiver operating characteristic curve analysis, NBI had higher area under curve (0.79 vs 0.65) as compared to WLE.

Conclusion: NBI morphological pattern is a useful tool in identifying patients with H. pylori-associated gastritis.

背景:幽门螺杆菌相关性胃炎的常规白光内镜(WLE)检查结果通常是非特异性的,可能与组织学无关。窄带成像(NBI)是一种用于胃粘膜血管和模式可视化的光学数字技术,可以提高识别能力。我们评估了NBI在检测幽门螺杆菌相关胃炎及其严重程度分类中的作用。方法:基于机构的前瞻性观察研究,于2021年5月至2022年10月进行。以慢性腹痛为表现的儿童(持续1个月)进行评估。符合条件的儿童接受NBI胃镜检查和胃活检进行快速脲酶检测和组织病理学检查。根据Alboudy等人的分类,将NBI胃镜检查结果分为5个等级。分析NBI分级与幽门螺杆菌胃炎存在及严重程度的组织病理学关系。结果:90名儿童(平均年龄12.65±3.91岁),52名男性(57.7%)接受胃镜检查,中位症状持续时间为4.5(3-12)个月。29例(32%)患者组织病理学检出幽门螺杆菌。组织病理学检查显示27/29(93.1%)幽门螺杆菌患儿黏膜异常。与NBI评分较低的患者相比,NBI评分较高(≥3)的患者幽门螺杆菌阳性胃炎明显更常见(61% vs10%)。结论:NBI形态学模式是鉴别幽门螺杆菌相关性胃炎患者的有用工具。
{"title":"UTILITY OF ENDOSCOPIC NARROW-BAND IMAGING FOR IDENTIFYING H. PYLORI-ASSOCIATED GASTRITIS IN CHILDREN.","authors":"Pooja Semwal, Rishi Bolia, Nowneet Kumar Bhat, Itish Patnaik, Prashant Durgapal, Rahul Sharma","doi":"10.1590/S0004-2803.24612024-067","DOIUrl":"10.1590/S0004-2803.24612024-067","url":null,"abstract":"<p><strong>Background: </strong>Conventional white light endoscopic (WLE) findings of H. pylori-associated gastritis are often non-specific and may not correlate with histology. Narrow band imaging (NBI), an optical digital technique employed for the visualization of vessels and patterns of gastric mucosa may improve identification. We evaluated the role of NBI in detecting H. pylori-associated gastritis and classifying its severity.</p><p><strong>Methods: </strong>Institution-based prospective observational study conducted between May 2021-October 2022. Children presenting with chronic abdominal pain (>1-month duration) were evaluated. Eligible children underwent gastroscopy with NBI and gastric biopsies for rapid urease test and histopathology. NBI gastroscopic findings were classified into five grades as per the classification by Alboudy et al. The association of NBI grade with the presence and severity of H. pylori gastritis on histopathology was analysed.</p><p><strong>Results: </strong>Ninety children (mean age 12.65±3.91 years), 52 (57.7%) males with median duration of symptoms of 4.5 (3-12) months underwent gastroscopy. H. pylori was detected on histopathology in 29 (32%) patients. NBI findings suggested a mucosal abnormality in 27/29 (93.1%) children with H. pylori on histopathology. H. pylori positive gastritis was significantly more common among those with higher (≥3) NBI grades as compared to those with lower NBI grades (61% vs10%, P<0.001). No significant association was found between NBI grade and the severity of H. pylori gastritis (P=0.75). NBI exhibited better sensitivity (0.82) compared to WLE (0.55) in identifying H. pylori-associated gastritis. On receiver operating characteristic curve analysis, NBI had higher area under curve (0.79 vs 0.65) as compared to WLE.</p><p><strong>Conclusion: </strong>NBI morphological pattern is a useful tool in identifying patients with H. pylori-associated gastritis.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24067"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DIAGNOSIS AND TREATMENT OF MICROSCOPIC COLITIS: POSITION PAPER ON BEHALF OF THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY. 显微镜下结肠炎的诊断和治疗:代表巴西胃肠病学联合会的立场文件。
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-102
Bruno César da Silva, Matheus Freitas Cardoso de Azevedo, Munique Kurtz de Mello, Mariana Rolim Fernandes Macedo, Jardel Soares Caetano, Antônio Carlos da Silva Moraes, Francisco Sérgio Rangel de Paula Pessoa, Míriam Aparecida da Silva Trevisan, Marcello Imbrizi

Background: Microscopic colitis (MC) is a chronic inflammatory condition of the colon, primarily characterized by watery diarrhea, with normal or near-normal endoscopic findings. It encompasses two main subtypes: lymphocytic colitis and collagenous colitis.

Objective: This position paper from the Brazilian Federation of Gastroenterology aims to review current evidence on the diagnosis and management of MC in Brazil, emphasizing the need for standardization across the country's healthcare systems.

Methods: A comprehensive review of the latest scientific literature, clinical guidelines, and consensus statements was performed, focusing on randomized clinical trials, meta-analyses, and cohort studies. The evidence was analyzed by a panel of gastroenterologists and pathologists specializing in MC. The recommendations were based on the consensus of the group, approved by the majority of the panel members.

Results: Histological examination with biopsies from multiple segments of the colon remains essential for the accurate diagnosis of MC, as endoscopic findings are often non-specific. Budesonide is the first-line treatment for inducing remission in most patients. However, alternatives such as immunosuppressants and biologics are available for those who are refractory to or intolerant of budesonide. Non-pharmacological interventions, including dietary and lifestyle modifications, can complement medical treatment. The need for long-term follow-up is highlighted due to the high recurrence rates and the impact of MC on the quality of life.

Conclusion: Standardizing the diagnosis and treatment of MC in Brazil is crucial, given the significant regional disparities in healthcare access. This position paper provides evidence-based recommendations to optimize care and improve patient outcomes across diverse clinical settings in Brazil. Further research is needed to address the gaps in understanding the epidemiology and management of MC in underserved regions.

背景:镜下结肠炎(MC)是一种结肠慢性炎症,主要表现为水样腹泻,内镜检查结果正常或接近正常。它包括两种主要亚型:淋巴细胞性结肠炎和胶原性结肠炎。目的:这篇来自巴西胃肠病学联合会的立场文件旨在回顾巴西MC诊断和管理的现有证据,强调全国医疗保健系统标准化的必要性。方法:对最新的科学文献、临床指南和共识声明进行全面回顾,重点是随机临床试验、荟萃分析和队列研究。证据由专门研究MC的胃肠病学家和病理学家组成的小组进行分析。这些建议是基于小组的共识,得到了小组大多数成员的批准。结果:由于内窥镜检查的结果通常是非特异性的,因此从结肠多节段活检的组织学检查仍然是准确诊断MC的必要条件。布地奈德是大多数患者诱导缓解的一线治疗。然而,对于布地奈德难治性或不耐受的患者,可使用免疫抑制剂和生物制剂等替代品。非药物干预,包括饮食和生活方式的改变,可以补充医疗。由于高复发率和MC对生活质量的影响,需要进行长期随访。结论:鉴于巴西医疗保健服务的地区差异,标准化MC的诊断和治疗至关重要。本立场文件提供了基于证据的建议,以优化巴西不同临床环境下的护理和改善患者预后。需要进一步的研究来解决在服务不足地区了解MC流行病学和管理方面的差距。
{"title":"DIAGNOSIS AND TREATMENT OF MICROSCOPIC COLITIS: POSITION PAPER ON BEHALF OF THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY.","authors":"Bruno César da Silva, Matheus Freitas Cardoso de Azevedo, Munique Kurtz de Mello, Mariana Rolim Fernandes Macedo, Jardel Soares Caetano, Antônio Carlos da Silva Moraes, Francisco Sérgio Rangel de Paula Pessoa, Míriam Aparecida da Silva Trevisan, Marcello Imbrizi","doi":"10.1590/S0004-2803.24612024-102","DOIUrl":"10.1590/S0004-2803.24612024-102","url":null,"abstract":"<p><strong>Background: </strong>Microscopic colitis (MC) is a chronic inflammatory condition of the colon, primarily characterized by watery diarrhea, with normal or near-normal endoscopic findings. It encompasses two main subtypes: lymphocytic colitis and collagenous colitis.</p><p><strong>Objective: </strong>This position paper from the Brazilian Federation of Gastroenterology aims to review current evidence on the diagnosis and management of MC in Brazil, emphasizing the need for standardization across the country's healthcare systems.</p><p><strong>Methods: </strong>A comprehensive review of the latest scientific literature, clinical guidelines, and consensus statements was performed, focusing on randomized clinical trials, meta-analyses, and cohort studies. The evidence was analyzed by a panel of gastroenterologists and pathologists specializing in MC. The recommendations were based on the consensus of the group, approved by the majority of the panel members.</p><p><strong>Results: </strong>Histological examination with biopsies from multiple segments of the colon remains essential for the accurate diagnosis of MC, as endoscopic findings are often non-specific. Budesonide is the first-line treatment for inducing remission in most patients. However, alternatives such as immunosuppressants and biologics are available for those who are refractory to or intolerant of budesonide. Non-pharmacological interventions, including dietary and lifestyle modifications, can complement medical treatment. The need for long-term follow-up is highlighted due to the high recurrence rates and the impact of MC on the quality of life.</p><p><strong>Conclusion: </strong>Standardizing the diagnosis and treatment of MC in Brazil is crucial, given the significant regional disparities in healthcare access. This position paper provides evidence-based recommendations to optimize care and improve patient outcomes across diverse clinical settings in Brazil. Further research is needed to address the gaps in understanding the epidemiology and management of MC in underserved regions.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24102"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASSOCIATION OF "METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC PANCREAS DISEASE" (MASPD) AND INSULIN RESISTANCE. “代谢功能障碍相关脂肪变性胰腺疾病”(masd)与胰岛素抵抗的关联
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-070
Luís Jesuino de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, Gustavo Magno Baptista, Catharina Peixoto Silva, Luís Matos de Oliveira

Background: To investigate the association between metabolic dysfunction-associated steatotic pancreas disease (MASPD) and insulin resistance (IR).

Methods: This cross-sectional study involved 157 participants diagnosed with MASPD based on ultrasonography criteria. Baseline demographic data were collected, including age, gender, and body mass index. Serum levels of fasting glucose, insulin, lipid profile (including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol), glycated hemoglobin and insulin were measured using standardized laboratory techniques. Abdominal ultrasonography was performed on all participants using convex transducer (frequency range, 3,5 MHz) by experienced radiologist blinded to the clinical data. The association between MASPD and IR was assessed using logistic regression analysis, adjusting for potential confounders. Statistical significance was set at a P-value <0.05.

Results: The logistic regression analysis was performed to verify whether MASPD was a risk factor for IR. After adjusting for gender and age, the results demonstrate a significant correlation between MASPD and markers of IR. TyG index: OR (95%IC) 5.72 (1.90-16.00), P 0.021, and HOMA -IR: OR (95%IC) 6.20 (2.1-22.00) P 0.037.

Conclusion: This study presents a description of MASPD and its association with IR indices. Our findings demonstrate a significant correlation between MASPD and markers of IR. These results suggest that MASPD may contribute to the development of insulin resistance and further highlight the importance of pancreatic health in metabolic disorders.

背景:探讨代谢功能障碍相关脂肪变性胰腺病(MASPD)与胰岛素抵抗(IR)之间的关系。方法:本横断面研究纳入157名基于超声诊断为MASPD的参与者。收集基线人口统计数据,包括年龄、性别和体重指数。空腹血糖、胰岛素、血脂(包括总胆固醇、甘油三酯、高密度脂蛋白胆固醇和低密度脂蛋白胆固醇)、糖化血红蛋白和胰岛素的血清水平采用标准化实验室技术进行测量。在不了解临床数据的情况下,由经验丰富的放射科医生使用凸形换能器(频率范围为3,5 MHz)对所有参与者进行腹部超声检查。使用逻辑回归分析评估MASPD和IR之间的关联,调整潜在的混杂因素。结果:采用logistic回归分析验证MASPD是否为IR的危险因素。在调整性别和年龄后,结果表明MASPD与IR标志物之间存在显著相关性。TyG指数:OR (95%IC) 5.72 (1.90-16.00), P 0.021; HOMA -IR: OR (95%IC) 6.20 (2.1-22.00) P 0.037。结论:本研究描述了MASPD及其与IR指标的关系。我们的研究结果表明,MASPD与IR标志物之间存在显著相关性。这些结果表明,MASPD可能有助于胰岛素抵抗的发展,并进一步强调胰腺健康在代谢紊乱中的重要性。
{"title":"ASSOCIATION OF \"METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC PANCREAS DISEASE\" (MASPD) AND INSULIN RESISTANCE.","authors":"Luís Jesuino de Oliveira Andrade, Gabriela Correia Matos de Oliveira, Alcina Maria Vinhaes Bittencourt, Gustavo Magno Baptista, Catharina Peixoto Silva, Luís Matos de Oliveira","doi":"10.1590/S0004-2803.24612024-070","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-070","url":null,"abstract":"<p><strong>Background: </strong>To investigate the association between metabolic dysfunction-associated steatotic pancreas disease (MASPD) and insulin resistance (IR).</p><p><strong>Methods: </strong>This cross-sectional study involved 157 participants diagnosed with MASPD based on ultrasonography criteria. Baseline demographic data were collected, including age, gender, and body mass index. Serum levels of fasting glucose, insulin, lipid profile (including total cholesterol, triglycerides, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol), glycated hemoglobin and insulin were measured using standardized laboratory techniques. Abdominal ultrasonography was performed on all participants using convex transducer (frequency range, 3,5 MHz) by experienced radiologist blinded to the clinical data. The association between MASPD and IR was assessed using logistic regression analysis, adjusting for potential confounders. Statistical significance was set at a P-value <0.05.</p><p><strong>Results: </strong>The logistic regression analysis was performed to verify whether MASPD was a risk factor for IR. After adjusting for gender and age, the results demonstrate a significant correlation between MASPD and markers of IR. TyG index: OR (95%IC) 5.72 (1.90-16.00), P 0.021, and HOMA -IR: OR (95%IC) 6.20 (2.1-22.00) P 0.037.</p><p><strong>Conclusion: </strong>This study presents a description of MASPD and its association with IR indices. Our findings demonstrate a significant correlation between MASPD and markers of IR. These results suggest that MASPD may contribute to the development of insulin resistance and further highlight the importance of pancreatic health in metabolic disorders.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24070"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MONITORING RESPIRATORY BIOMECHANICS, LUNG CAPACITY AND MOBILITY IN BARIATRIC SURGERY: PERIOPERATIVE ANALYSIS. 监测呼吸生物力学,肺活量和活动在减肥手术:围手术期分析。
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-066
Danusa Rossi, Ney Ricardo de Alencastro Stedile, Elias Aguiar da Silva, Danielly de Gasperi, Luciano Neto Santos, Bruna Eibel

Background: Several preoperative pulmonary assessment protocols have been established over the years, but assessments of this magnitude are lacking in the bariatric population. Therefore, the assessment of lung capacity, maximum inspiratory and expiratory pressures, the peak expiratory flow and mobility can be predictors of operative safety and determine the time of hospital discharge.

Objective: To evaluate lung capacity, respiratory muscle strength and level of mobility in the pre, immediate post-operative and hospital discharge of patients undergoing bariatric surgery.

Methods: Cross-sectional study, with 38 bariatric patients undergoing surgical intervention. Anthropometric data, lung function, respiratory muscle strength and mobility level were evaluated pre-, post-operatively and at hospital discharge. Statistical Analysis: GEE; P<0.05.

Results: In relation to the preoperative period, in the POi there was a significant reduction in mobility, respiratory muscle strength, FVC, FEV1, PEF and a significant increase in these variables at hospital discharge, however, not reaching the same conditions as the preoperative period, except the Tiffeneau index (P<0.644).

Conclusion: Bariatric surgery impacts the mobility, respiratory muscle strength and lung function of patients with grade II and III obesity, leading to longer hospital stays and possible major complications. The role of physiotherapy in the prevention and rehabilitation of these patients must be strongly considered.

背景:多年来已经建立了几种术前肺部评估方案,但在肥胖人群中缺乏这种规模的评估。因此,肺活量、最大吸气和呼气压力、呼气峰流量和活动性的评估可以作为手术安全性的预测指标,并确定出院时间。目的:评价减肥手术患者术前、术后及出院时的肺活量、呼吸肌力量和活动水平。方法:对38例接受手术治疗的肥胖患者进行横断面研究。在术前、术后和出院时评估人体测量数据、肺功能、呼吸肌力量和活动水平。统计分析:GEE;结果:与术前相比,POi患者的活动性、呼吸肌力量、FVC、FEV1、PEF均显著降低,出院时这些指标均显著升高,但除Tiffeneau指数(p)外,均未达到术前水平。减肥手术会影响II级和III级肥胖患者的活动能力、呼吸肌力量和肺功能,导致更长的住院时间和可能的主要并发症。物理治疗在这些患者的预防和康复中的作用必须得到强烈的考虑。
{"title":"MONITORING RESPIRATORY BIOMECHANICS, LUNG CAPACITY AND MOBILITY IN BARIATRIC SURGERY: PERIOPERATIVE ANALYSIS.","authors":"Danusa Rossi, Ney Ricardo de Alencastro Stedile, Elias Aguiar da Silva, Danielly de Gasperi, Luciano Neto Santos, Bruna Eibel","doi":"10.1590/S0004-2803.24612024-066","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-066","url":null,"abstract":"<p><strong>Background: </strong>Several preoperative pulmonary assessment protocols have been established over the years, but assessments of this magnitude are lacking in the bariatric population. Therefore, the assessment of lung capacity, maximum inspiratory and expiratory pressures, the peak expiratory flow and mobility can be predictors of operative safety and determine the time of hospital discharge.</p><p><strong>Objective: </strong>To evaluate lung capacity, respiratory muscle strength and level of mobility in the pre, immediate post-operative and hospital discharge of patients undergoing bariatric surgery.</p><p><strong>Methods: </strong>Cross-sectional study, with 38 bariatric patients undergoing surgical intervention. Anthropometric data, lung function, respiratory muscle strength and mobility level were evaluated pre-, post-operatively and at hospital discharge. Statistical Analysis: GEE; P<0.05.</p><p><strong>Results: </strong>In relation to the preoperative period, in the POi there was a significant reduction in mobility, respiratory muscle strength, FVC, FEV1, PEF and a significant increase in these variables at hospital discharge, however, not reaching the same conditions as the preoperative period, except the Tiffeneau index (P<0.644).</p><p><strong>Conclusion: </strong>Bariatric surgery impacts the mobility, respiratory muscle strength and lung function of patients with grade II and III obesity, leading to longer hospital stays and possible major complications. The role of physiotherapy in the prevention and rehabilitation of these patients must be strongly considered.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24066"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A GLOBAL VIEW OF HEPATOLOGY COLLABORATION: INSIGHTS AND FUTURE DIRECTIONS FROM 30 YEARS OF NETWORK ANALYSIS (1994-2023). 肝病学合作的全球视角:来自30年网络分析(1994-2023)的见解和未来方向。
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-103
Naruaki Ogasawara

Background: This study aims to analyze the structural dynamics of research collaboration in hepatology over a 30-year period (1994-2023), focusing on co-authorship networks. By examining data from the Web of Science Core Collection, the study explores key metrics such as network density, clustering coefficient, and centrality measures, providing insights into how collaborative efforts have shaped the field of hepatology.

Methods: Using Python (Version 3.10.5) in the PyCharm environment, I conducted a network analysis of 9,278 hepatology-related publications. Macro-level indicators, including network density, clustering coefficient, number of components, and average path length, were used to evaluate overall network structure. Micro-level metrics, such as degree centrality, closeness centrality, and betweenness centrality, were employed to assess the influence of individual researchers within the network.

Results: The analysis showed an increase in network fragmentation, with components rising from 338 in 1994-2003 to 1,302 by 2014-2023. Despite the growing number of publications, network density remained consistently low, indicating limited direct collaboration. However, high clustering coefficients across all periods suggest that collaborations form in tightly connected groups. This study identified key researchers such as LAMBERTINI A. (1994-2003), Manns, Michael P. (2004-2013), and Berg, Thomas (2014-2023), who played central roles, linking different research clusters and facilitating collaboration across groups.

Conclusion: Hepatology research has experienced significant growth in publications over the past 30 years, yet collaborative efforts remain localized, with increasing network fragmentation. Identifying central researchers who bridge gaps between otherwise disconnected groups is essential to fostering broader collaboration. This analysis underscores the importance of strengthening international cooperation and collaborative research to address the increasingly complex and region-specific liver diseases worldwide.

背景:本研究旨在分析30年间(1994-2023年)肝病学研究合作的结构动态,重点关注合著者网络。通过检查Web of Science核心收集的数据,该研究探索了关键指标,如网络密度、聚类系数和中心性度量,为合作努力如何塑造肝病学领域提供了见解。方法:在PyCharm环境中使用Python (Version 3.10.5),对9278篇肝病学相关出版物进行了网络分析。宏观层面的指标,包括网络密度、聚类系数、组件数、平均路径长度等,用来评价整体网络结构。微观层面的指标,如度中心性、接近中心性和中间中心性,被用来评估个别研究人员在网络中的影响。结果:分析显示网络碎片化程度增加,组件从1994-2003年的338个增加到2014-2023年的1302个。尽管出版物数量不断增加,但网络密度一直很低,表明直接合作有限。然而,所有时期的高聚类系数表明协作是在紧密联系的群体中形成的。本研究确定了LAMBERTINI A.(1994-2003)、Manns, Michael P.(2004-2013)和Berg, Thomas(2014-2023)等关键研究人员,他们在连接不同的研究集群和促进跨小组合作方面发挥了核心作用。结论:在过去的30年里,肝病学研究在出版物上经历了显著的增长,但合作努力仍然局限于局部,网络碎片化程度越来越高。确定能够在互不联系的小组之间架起桥梁的核心研究人员,对于促进更广泛的合作至关重要。这一分析强调了加强国际合作和合作研究的重要性,以解决世界范围内日益复杂和区域特异性的肝脏疾病。
{"title":"A GLOBAL VIEW OF HEPATOLOGY COLLABORATION: INSIGHTS AND FUTURE DIRECTIONS FROM 30 YEARS OF NETWORK ANALYSIS (1994-2023).","authors":"Naruaki Ogasawara","doi":"10.1590/S0004-2803.24612024-103","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-103","url":null,"abstract":"<p><strong>Background: </strong>This study aims to analyze the structural dynamics of research collaboration in hepatology over a 30-year period (1994-2023), focusing on co-authorship networks. By examining data from the Web of Science Core Collection, the study explores key metrics such as network density, clustering coefficient, and centrality measures, providing insights into how collaborative efforts have shaped the field of hepatology.</p><p><strong>Methods: </strong>Using Python (Version 3.10.5) in the PyCharm environment, I conducted a network analysis of 9,278 hepatology-related publications. Macro-level indicators, including network density, clustering coefficient, number of components, and average path length, were used to evaluate overall network structure. Micro-level metrics, such as degree centrality, closeness centrality, and betweenness centrality, were employed to assess the influence of individual researchers within the network.</p><p><strong>Results: </strong>The analysis showed an increase in network fragmentation, with components rising from 338 in 1994-2003 to 1,302 by 2014-2023. Despite the growing number of publications, network density remained consistently low, indicating limited direct collaboration. However, high clustering coefficients across all periods suggest that collaborations form in tightly connected groups. This study identified key researchers such as LAMBERTINI A. (1994-2003), Manns, Michael P. (2004-2013), and Berg, Thomas (2014-2023), who played central roles, linking different research clusters and facilitating collaboration across groups.</p><p><strong>Conclusion: </strong>Hepatology research has experienced significant growth in publications over the past 30 years, yet collaborative efforts remain localized, with increasing network fragmentation. Identifying central researchers who bridge gaps between otherwise disconnected groups is essential to fostering broader collaboration. This analysis underscores the importance of strengthening international cooperation and collaborative research to address the increasingly complex and region-specific liver diseases worldwide.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24103"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TRANSLATION, CROSS-CULTURAL ADAPTATION, AND VALIDATION OF THE IBD DISK FOR USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN THE BRAZILIAN POPULATION. 巴西人群中炎症性肠病患者ibd磁盘的翻译、跨文化适应和验证
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-058
Cintia Maura Caseiro Nigro, Sandro da Costa Ferreira, Vanessa Foresto Machado, Marley Ribeiro Feitosa, José Joaquim Ribeiro da Rocha, Omar Féres, Rogério Serafim Parra

Background: The inflammatory bowel disease (IBD) disk is a simple and quick method to assess the level of disability experienced by patients with IBD. It has been already translated and validated in European countries, however it was not yet translated and validated to use in Brazil.

Objective: This study was performed to translate and validate a Brazilian version of the IBD-Disk. Methods: The original version of the IBD-Disk was translated into Portuguese (Brazilian) and administered to patients with IBD in a referral center in Brazil. This step included direct translation by two native-language expert translators, followed by back translation by two expert translators, with synthesis of the two versions after each step analyzed by a committee of experts and tested in a pilot group. After obtaining the cross-cultural adaptation of the instrument, a validation process was conducted.

Results: A total of 198 patients were included (Crohn's disease, n=149, 75.2%). The model presented satisfactory parameters regarding precision (ORION=0.93), representativeness of the construct (FDI=0.97), sensitivity (SR=3.77), expected percentage of the factor (EPTD=94.3%) and replicability by the latent G-H index (0.93) and observed (0.89), revealing how well the factor can be identified by the continuous attentive response variables and observed items. The item-total correlation coefficients ranged from 0.518 to 0.750, considered ideal. The total instrument presented α=0.921 and ω=0.922, values above the cut-off point and are therefore considered satisfactory.

Conclusion: The translation and cross-cultural adaptation of the IBD-Disk into Brazi-lian-Portuguese (BR-IBD Disk) proved to be a reliable and valid tool in detecting and assessing IBD-related disability in a Brazilian cohort.

背景:炎症性肠病(IBD)盘是评估IBD患者残疾水平的一种简单快速的方法。它已经在欧洲国家被翻译和验证,但是它还没有被翻译和验证在巴西使用。目的:本研究进行了翻译和验证巴西版本的IBD-Disk。方法:将原始版本的IBD- disk翻译成葡萄牙语(巴西语),并在巴西的一家转诊中心给IBD患者使用。这一步骤包括由两名母语翻译专家直接翻译,然后由两名翻译专家反向翻译,每一步由专家委员会分析并在试点小组中进行测试后,对两个版本进行综合。在获得仪器的跨文化适应性后,进行验证过程。结果:共纳入198例患者(克罗恩病,n=149, 75.2%)。该模型在精度(ORION=0.93)、结构代表性(FDI=0.97)、敏感性(SR=3.77)、预期因子百分比(EPTD=94.3%)和潜在G-H指数(0.93)和观察值(0.89)的可复制性方面给出了令人满意的参数,揭示了连续注意反应变量和观察项目对因子的识别程度。项目总数的相关系数在0.518到0.750之间,被认为是理想的。总仪器呈现α=0.921和ω=0.922,值高于截止点,因此被认为是令人满意的。结论:将IBD-Disk翻译成巴西-葡萄牙语(BR-IBD Disk)是检测和评估巴西队列ibd相关残疾的可靠和有效的工具。
{"title":"TRANSLATION, CROSS-CULTURAL ADAPTATION, AND VALIDATION OF THE IBD DISK FOR USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IN THE BRAZILIAN POPULATION.","authors":"Cintia Maura Caseiro Nigro, Sandro da Costa Ferreira, Vanessa Foresto Machado, Marley Ribeiro Feitosa, José Joaquim Ribeiro da Rocha, Omar Féres, Rogério Serafim Parra","doi":"10.1590/S0004-2803.24612024-058","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-058","url":null,"abstract":"<p><strong>Background: </strong>The inflammatory bowel disease (IBD) disk is a simple and quick method to assess the level of disability experienced by patients with IBD. It has been already translated and validated in European countries, however it was not yet translated and validated to use in Brazil.</p><p><strong>Objective: </strong>This study was performed to translate and validate a Brazilian version of the IBD-Disk. Methods: The original version of the IBD-Disk was translated into Portuguese (Brazilian) and administered to patients with IBD in a referral center in Brazil. This step included direct translation by two native-language expert translators, followed by back translation by two expert translators, with synthesis of the two versions after each step analyzed by a committee of experts and tested in a pilot group. After obtaining the cross-cultural adaptation of the instrument, a validation process was conducted.</p><p><strong>Results: </strong>A total of 198 patients were included (Crohn's disease, n=149, 75.2%). The model presented satisfactory parameters regarding precision (ORION=0.93), representativeness of the construct (FDI=0.97), sensitivity (SR=3.77), expected percentage of the factor (EPTD=94.3%) and replicability by the latent G-H index (0.93) and observed (0.89), revealing how well the factor can be identified by the continuous attentive response variables and observed items. The item-total correlation coefficients ranged from 0.518 to 0.750, considered ideal. The total instrument presented α=0.921 and ω=0.922, values above the cut-off point and are therefore considered satisfactory.</p><p><strong>Conclusion: </strong>The translation and cross-cultural adaptation of the IBD-Disk into Brazi-lian-Portuguese (BR-IBD Disk) proved to be a reliable and valid tool in detecting and assessing IBD-related disability in a Brazilian cohort.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e23058"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EARLY NONINVASIVE EVALUATION OF LIVER FIBROSIS AFTER HEPATITIS C TREATMENT: THE IMPACT OF INFLAMMATION. 丙型肝炎治疗后肝纤维化的早期无创评估:炎症的影响。
Q2 Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI: 10.1590/S0004-2803.24612024-043
João Batista Xavier, Joel Schmillevitch, Christini Emori, Silvia Uehara, Eunice Jadriana Nunes, Maria Lucia Ferraz

Background: Liver biopsy (LB) is still the gold standard method for assessing hepatic fibrosis (HF), associated diseases, and liver inflammation. Nowadays, noninvasive techniques such as Acoustic radiation force impulse (ARFI) elastography have been introduced instead of liver biopsy. However, there are controversies about the time it should be performed after treatment for hepatitis C virus (HCV).

Objective: To evaluate hepatic fibrosis using ARFI technology before and after successive treatments for chronic HCV.

Methods: We prospectively included 50 adult patients with chronic HCV (genotype 1). Patients were first submitted to triple therapy with first-generation protease inhibitors (boceprevir and telaprevir) at the hepatitis division of the Gastroenterology Department of the Federal University of São Paulo. The non-responders underwent re-treatment with interferon-free direct-acting antiviral agents (DDAs - sofosbuvir associated with daclatasvir or simeprevir). Assessment of hepatic stiffness by ARFI was performed before and after the first treatment and before and after the re-treatment with DDAs.

Results: ARFI values decreased significantly after treatments. In patients on first-generation protease inhibitor therapy and achieving sustained virological response (SVR), ARFI decreased from 2.41±0.58 pre-treatment to 2.02+/-0.58 (P<0.042) post-treatment. In patients who did not reach SVR, that is, non-responders, a significant reduction was similarly observed (2.39±0.63 to 2.03±0.54; P<0.001 before and after treatment, respectively). Before starting the re-treatment, non-responders had elevated ARFI values again, dropping after SVR following re-treatment (from 2.46±0.57 to 1.45±0.68, P<0.004). Laboratory parameters such as AST and ALT were directly correlated to ARFI elastography.

Conclusion: The evaluation of hepatic elastography by the ARFI method before and after (6 - 9 months) successive treatment of hepatitis C in responders and non-responders led to the conclusion that the reduction of elastography parameters seems to be related to a decrease in hepatic inflammation rather than a reduction in fibrosis per se.

背景:肝活检(LB)仍然是评估肝纤维化(HF)、相关疾病和肝脏炎症的金标准方法。目前,无创技术如声辐射力脉冲(ARFI)弹性成像已经取代肝脏活检。然而,对于丙型肝炎病毒(HCV)治疗后应在何时进行该手术存在争议。目的:应用ARFI技术评价慢性丙型肝炎连续治疗前后肝纤维化情况。方法:我们前瞻性地纳入了50例慢性HCV(基因型1)的成年患者。患者首先在圣保罗联邦大学消化内科肝炎科接受第一代蛋白酶抑制剂(boceprevir和telaprevir)的三联治疗。无应答者接受无干扰素直接作用抗病毒药物(DDAs - sofosbuvir联合daclatasvir或simeprevir)的再次治疗。第一次治疗前后和dda再治疗前后分别用ARFI评估肝脏僵硬度。结果:治疗后ARFI值明显降低。在接受第一代蛋白酶抑制剂治疗并获得持续病毒学应答(SVR)的患者中,ARFI从治疗前的2.41±0.58降至2.02+/-0.58 (p)。在对丙型肝炎有反应者和无反应者进行连续治疗前后(6 - 9个月)用ARFI方法对肝弹性成像的评估得出结论,弹性成像参数的减少似乎与肝脏炎症的减少有关,而不是纤维化本身的减少。
{"title":"EARLY NONINVASIVE EVALUATION OF LIVER FIBROSIS AFTER HEPATITIS C TREATMENT: THE IMPACT OF INFLAMMATION.","authors":"João Batista Xavier, Joel Schmillevitch, Christini Emori, Silvia Uehara, Eunice Jadriana Nunes, Maria Lucia Ferraz","doi":"10.1590/S0004-2803.24612024-043","DOIUrl":"https://doi.org/10.1590/S0004-2803.24612024-043","url":null,"abstract":"<p><strong>Background: </strong>Liver biopsy (LB) is still the gold standard method for assessing hepatic fibrosis (HF), associated diseases, and liver inflammation. Nowadays, noninvasive techniques such as Acoustic radiation force impulse (ARFI) elastography have been introduced instead of liver biopsy. However, there are controversies about the time it should be performed after treatment for hepatitis C virus (HCV).</p><p><strong>Objective: </strong>To evaluate hepatic fibrosis using ARFI technology before and after successive treatments for chronic HCV.</p><p><strong>Methods: </strong>We prospectively included 50 adult patients with chronic HCV (genotype 1). Patients were first submitted to triple therapy with first-generation protease inhibitors (boceprevir and telaprevir) at the hepatitis division of the Gastroenterology Department of the Federal University of São Paulo. The non-responders underwent re-treatment with interferon-free direct-acting antiviral agents (DDAs - sofosbuvir associated with daclatasvir or simeprevir). Assessment of hepatic stiffness by ARFI was performed before and after the first treatment and before and after the re-treatment with DDAs.</p><p><strong>Results: </strong>ARFI values decreased significantly after treatments. In patients on first-generation protease inhibitor therapy and achieving sustained virological response (SVR), ARFI decreased from 2.41±0.58 pre-treatment to 2.02+/-0.58 (P<0.042) post-treatment. In patients who did not reach SVR, that is, non-responders, a significant reduction was similarly observed (2.39±0.63 to 2.03±0.54; P<0.001 before and after treatment, respectively). Before starting the re-treatment, non-responders had elevated ARFI values again, dropping after SVR following re-treatment (from 2.46±0.57 to 1.45±0.68, P<0.004). Laboratory parameters such as AST and ALT were directly correlated to ARFI elastography.</p><p><strong>Conclusion: </strong>The evaluation of hepatic elastography by the ARFI method before and after (6 - 9 months) successive treatment of hepatitis C in responders and non-responders led to the conclusion that the reduction of elastography parameters seems to be related to a decrease in hepatic inflammation rather than a reduction in fibrosis per se.</p>","PeriodicalId":35671,"journal":{"name":"Arquivos de Gastroenterologia","volume":"61 ","pages":"e24043"},"PeriodicalIF":0.0,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142956115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arquivos de Gastroenterologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1